Department of Health

OncoRes Medical today announced it has closed an AUD $27M private funding round (‘the Funding round’) to progress clinical development and regulatory milestones for its Quantitative Micro-Elastography (QME) Imaging System, Elora™.

Perth-based OncoRes Medical has secured $27 million from Brandon Capital's BB6 Fund, Morgans, Radar Ventures and others to advance its Elora breast-surgery imaging device through an Australian clinical trial toward FDA approval.

Also oncoresmedical.com

From lab to launch: How CSIRO ON Accelerate 9 is powering the next big deep tech startups

CSIRO's ninth ON accelerator cohort of eleven research teams has completed the program, with three members winning grants, two filing patents, and individual awards announced.

Also Business News Australia

Dr Marcus Tan Joins Integral As Executive Chair

Startup News reports Dr Marcus Tan, who founded and led HealthEngine, has taken the Executive Chair role at Perth leadership-development firm Integral, which earlier raised angel money including from Rayn Ong.

WA medtech companies ready to pitch at premier industry event

Eleven WA health organisations, including grant-backed Metabolic Health Solutions, head to the AusMedtech 2024 conference with ministerial support to present devices and pursue new partners.

State Government Backs OncoRes Medical with Funding to Manufacture Digital Cancer ImagingDevice in WA

OncoRes Medical has received a $3 million WA government grant to manufacture its surgical cancer-imaging device locally, its latest funding after a 2022 Series A2 and earlier state and federal grants.

Also Brandon BioCatalyst portfolio·Startup News (WA)

Australian medical device company secures additional $12.5m to advance its breast cancer imaging system towards clinical trials

Perth medtech OncoRes Medical announced $12.5 million: a $9.5 million Series A2 co-led by Brandon Capital and Australian Unity, plus a $3 million government grant, and hired a new R&D vice president.

Also Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Startup News (WA)

Personal care company selling in 12 countries | Awarded Australian government grant | $1.5M already raised

Wholesale Investor profiles Dr Mark's HyGenie, an oral hygiene company that has raised $1.5 million in a Series A and received a $1 million Australian government commercialisation grant, and is now offering $5 million.

IDT to receive $11.4m readying for mRNA manufacture

IDT Australia has secured an $11.44 million federal government payment to prepare its Melbourne sterile facility for potential mRNA vaccine production, with $7.5 million already received; vaccine candidate talks with Monash continue.

Manufacturing news briefs – stories you might have missed

Roundup of manufacturing updates: a psychedelics licence for a cannabis producer, a hydrogen grant, patents, a wellness brand acquisition, government program support, and a Turkish diagnostic distribution deal.

OncoRes Medical receives $150,000 funding boost from Western Australian Government

The Western Australian Government is putting $150,000 from its New Industries Fund into medtech startup OncoRes Medical to expand R&D and jobs, with the company also recalling $7.5 million raised from MRCF.

Also Brandon Capital portfolio·Startup News (WA)

OncoRes Medical wins IGNITE Madness 2020

Perth medtech OncoRes Medical won the IGNITE Madness 2020 pitch competition in Houston, earning a US$10,000 cash prize plus a Texas Medical Centre Ventures investment prize valued above US$100,000.

OncoRes Medical awarded prestigious research funding

OncoRes Medical received grant funding through the third round of MTPConnect's BMTH program to develop a second-generation imaging device for breast-conserving surgery, the article's profile states.

Also Brandon Capital portfolio·Brandon Capital portfolio·Startup News (WA)

Investing in private assets is ‘way to go’: Odell

Ellerston Capital's JAADE private assets fund, co-led by ex-Aristocrat CEO Jamie Odell, reports a strong first year and ambitions to raise up to $500m; its holdings include Mable, Camms and SiteMinder.

Also Startup Daily·Startup Daily·Startup Daily

5 things you should know about tech today

Tech roundup covering Apple and Google's contact-tracing API fixing CovidSafe, Afterpay's US user growth, Tesla dropping a lawsuit, and Bevan Slattery selling a third of his Megaport stake for $65 million.

MRCF launches Perth-based biotech developing new treatment for Cystic Fibrosis

The MRCF Biomedical Translation Fund has launched Respirion Pharmaceuticals, a Perth biotech developing an inhaled antibiotic for cystic fibrosis, committing up to A$20 million, with up to US$3 million from the CF Foundation.

Also Brandon BioCatalyst portfolio·@AuManufacturing